Enlight Biosciences forms new partnerships with AstraZeneca and Novo Nordisk

Thursday, 15 December 2011

This partnership reflects AstraZeneca’s commitment to accessing and fostering innovation that exists outside of our own labs

Menelas Pangalos, Executive Vice President, Innovative Medicines


Enlight Biosciences LLC announced today that it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight, AstraZeneca and Novo Nordisk will have the opportunity to collaborate and invest in the development of potentially transformational technologies with application to their therapeutic programs.

Enlight was created by PureTech Ventures in partnership with major pharmaceutical companies and academic luminaries to proactively address critical unmet industry needs.

View full press release

Download our brochure

Download your comprehensive guide to partnering with us.

Meet us at an event

Calendar iconView our full event calendar to see events we are attending.

View calendar